Gyroscope bags $148M for AMD gene therapy trials, mulls IPO

Gyroscope bags $148M for AMD gene therapy trials, mulls IPO

Source: 
Fierce Biotech
snippet: 

Gyroscope Therapeutics has raised $148 million to advance a pipeline of ocular gene therapies. The series C, which could be a precursor to an IPO, positions Gyroscope to build on recent early-phase data on lead candidate GT005.